Xenetic Biosciences
XBIO • NASDAQ
Xenetic Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James F. Parslow, with a market cap of $6.2M.
CEOJames F. Parslow
Next Earnings
Upcoming earnings announcement for Xenetic Biosciences
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 12 earnings reports for Xenetic Biosciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | Q4 2025 | -$0.22Est: -$0.52 | +57.7% | $766.3KEst: $525.0K | +46.0% |  10-K |
| Nov 13, 2025 | Q3 2025 | -$0.33Est: -$0.51 | +35.3% | $1.0MEst: $525.0K | +95.6% | 10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.45Est: -$0.65 | +30.8% | $589.9KEst: $545.2K | +8.2% | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.59Est: -$0.72 | +18.1% | $593.3KEst: $516.0K | +15.0% | 10-Q |
| Mar 18, 2025 | Q4 2024 | -$0.68Est: -$0.20 | -240.0% | $648.8KEst: $230.0K | +182.1% | 10-K/A |
| Nov 12, 2024 | Q3 2024 | -$0.28Est: -$0.14 | -100.0% | $614.2KEst: $750.0K | -18.1% | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.83Est: -$0.15 | -453.3% | $726.4KEst: $570.0K | +27.4% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.78Est: -$0.79 | +1.3% | $510.8KEst: $650.0K | -21.4% | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.77Est: -$0.87 | +11.5% | $672.0KEst: $680.0K | -1.2% | — |
| Nov 10, 2023 | Q3 2023 | -$0.69Est: -$1.12 | +38.4% | $611.2KEst: $460.0K | +32.9% | — |
| Aug 11, 2023 | Q2 2023 | -$0.69Est: -$1.13 | +38.9% | $651.0KEst: $440.0K | +48.0% | — |
| May 11, 2023 | Q1 2023 | -$0.60Est: -$1.10 | +45.5% | $605.8KEst: $410.0K | +47.8% | — |